Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleSpecial Issue on Drug Delivery Technologies

Long-Term Engraftment of Human Cardiomyocytes Combined with Biodegradable Microparticles Induces Heart Repair

Laura Saludas, Elisa Garbayo, Manuel Mazo, Beatriz Pelacho, Gloria Abizanda, Olalla Iglesias-Garcia, Angel Raya, Felipe Prósper and María J. Blanco-Prieto
Journal of Pharmacology and Experimental Therapeutics September 2019, 370 (3) 761-771; DOI: https://doi.org/10.1124/jpet.118.256065
Laura Saludas
Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain (L.S., E.G., M.J.B.-P.); Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (L.S., E.G., M.M., B.P., G.A., F.P., M.J.B.-P.); Hematology and Cell Therapy, Clínica Universidad de Navarra and Foundation for Applied Medical Research, Pamplona, Spain (M.M., B.P., G.A., F.P.); Center of Regenerative Medicine in Barcelona (CRMB), Hospitalet de Llobregat, Barcelona, Spain, Center for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain (O.I.-G., A.R.) and Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (A.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisa Garbayo
Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain (L.S., E.G., M.J.B.-P.); Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (L.S., E.G., M.M., B.P., G.A., F.P., M.J.B.-P.); Hematology and Cell Therapy, Clínica Universidad de Navarra and Foundation for Applied Medical Research, Pamplona, Spain (M.M., B.P., G.A., F.P.); Center of Regenerative Medicine in Barcelona (CRMB), Hospitalet de Llobregat, Barcelona, Spain, Center for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain (O.I.-G., A.R.) and Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (A.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elisa Garbayo
Manuel Mazo
Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain (L.S., E.G., M.J.B.-P.); Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (L.S., E.G., M.M., B.P., G.A., F.P., M.J.B.-P.); Hematology and Cell Therapy, Clínica Universidad de Navarra and Foundation for Applied Medical Research, Pamplona, Spain (M.M., B.P., G.A., F.P.); Center of Regenerative Medicine in Barcelona (CRMB), Hospitalet de Llobregat, Barcelona, Spain, Center for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain (O.I.-G., A.R.) and Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (A.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manuel Mazo
Beatriz Pelacho
Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain (L.S., E.G., M.J.B.-P.); Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (L.S., E.G., M.M., B.P., G.A., F.P., M.J.B.-P.); Hematology and Cell Therapy, Clínica Universidad de Navarra and Foundation for Applied Medical Research, Pamplona, Spain (M.M., B.P., G.A., F.P.); Center of Regenerative Medicine in Barcelona (CRMB), Hospitalet de Llobregat, Barcelona, Spain, Center for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain (O.I.-G., A.R.) and Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (A.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Beatriz Pelacho
Gloria Abizanda
Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain (L.S., E.G., M.J.B.-P.); Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (L.S., E.G., M.M., B.P., G.A., F.P., M.J.B.-P.); Hematology and Cell Therapy, Clínica Universidad de Navarra and Foundation for Applied Medical Research, Pamplona, Spain (M.M., B.P., G.A., F.P.); Center of Regenerative Medicine in Barcelona (CRMB), Hospitalet de Llobregat, Barcelona, Spain, Center for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain (O.I.-G., A.R.) and Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (A.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olalla Iglesias-Garcia
Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain (L.S., E.G., M.J.B.-P.); Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (L.S., E.G., M.M., B.P., G.A., F.P., M.J.B.-P.); Hematology and Cell Therapy, Clínica Universidad de Navarra and Foundation for Applied Medical Research, Pamplona, Spain (M.M., B.P., G.A., F.P.); Center of Regenerative Medicine in Barcelona (CRMB), Hospitalet de Llobregat, Barcelona, Spain, Center for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain (O.I.-G., A.R.) and Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (A.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olalla Iglesias-Garcia
Angel Raya
Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain (L.S., E.G., M.J.B.-P.); Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (L.S., E.G., M.M., B.P., G.A., F.P., M.J.B.-P.); Hematology and Cell Therapy, Clínica Universidad de Navarra and Foundation for Applied Medical Research, Pamplona, Spain (M.M., B.P., G.A., F.P.); Center of Regenerative Medicine in Barcelona (CRMB), Hospitalet de Llobregat, Barcelona, Spain, Center for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain (O.I.-G., A.R.) and Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (A.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Felipe Prósper
Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain (L.S., E.G., M.J.B.-P.); Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (L.S., E.G., M.M., B.P., G.A., F.P., M.J.B.-P.); Hematology and Cell Therapy, Clínica Universidad de Navarra and Foundation for Applied Medical Research, Pamplona, Spain (M.M., B.P., G.A., F.P.); Center of Regenerative Medicine in Barcelona (CRMB), Hospitalet de Llobregat, Barcelona, Spain, Center for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain (O.I.-G., A.R.) and Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (A.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Felipe Prósper
María J. Blanco-Prieto
Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain (L.S., E.G., M.J.B.-P.); Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain (L.S., E.G., M.M., B.P., G.A., F.P., M.J.B.-P.); Hematology and Cell Therapy, Clínica Universidad de Navarra and Foundation for Applied Medical Research, Pamplona, Spain (M.M., B.P., G.A., F.P.); Center of Regenerative Medicine in Barcelona (CRMB), Hospitalet de Llobregat, Barcelona, Spain, Center for Networked Biomedical Research on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain (O.I.-G., A.R.) and Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (A.R.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for María J. Blanco-Prieto
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 370 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 370, Issue 3
1 Sep 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Long-Term Engraftment of Human Cardiomyocytes Combined with Biodegradable Microparticles Induces Heart Repair
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleSpecial Issue on Drug Delivery Technologies

hiPSC-CM–Laden MPs Repair the Heart after Myocardial Infarction

Laura Saludas, Elisa Garbayo, Manuel Mazo, Beatriz Pelacho, Gloria Abizanda, Olalla Iglesias-Garcia, Angel Raya, Felipe Prósper and María J. Blanco-Prieto
Journal of Pharmacology and Experimental Therapeutics September 1, 2019, 370 (3) 761-771; DOI: https://doi.org/10.1124/jpet.118.256065

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleSpecial Issue on Drug Delivery Technologies

hiPSC-CM–Laden MPs Repair the Heart after Myocardial Infarction

Laura Saludas, Elisa Garbayo, Manuel Mazo, Beatriz Pelacho, Gloria Abizanda, Olalla Iglesias-Garcia, Angel Raya, Felipe Prósper and María J. Blanco-Prieto
Journal of Pharmacology and Experimental Therapeutics September 1, 2019, 370 (3) 761-771; DOI: https://doi.org/10.1124/jpet.118.256065
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CEA-Targeting Nanoparticles for CRC Treatment
  • Intranasal CSA in Nanoemulsion
  • Ultrasound-Triggered Combinational Therapy
Show more Special Issue on Drug Delivery Technologies

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics